COMBINATION OF AN MCL-1 INHIBITOR AND A STANDARD TREATMENT FOR HEMATOLOGICAL CANCER, USES AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS

MA49444AUndetermined Publication Date: 2020-04-29LES LAB SERVIER SA +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA49444
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2017-09-06
Filing Date: 2018-06-21
Publication Date: 2020-04-29

Application Information

Patent Timeline

06 Sep 2017

Priority

21 Jun 2018

Application

MA49444

29 Apr 2020

Publication

MA49444A

IPC: A61K31/5377; A61K31/519; A61K31/55; A61K45/06; A61P35/00

CPC: A61K45/06; A61K31/519; A61P35/00; A61P35/02; A61K2300/00; A61K31/5377; A61K31/55; A61K31/704

Inventors: GENESTE Olivier; MARAGNO Ana-Leticia

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.